← All organizations

DongWha Pharmaceutical Company

For profitWebsite ↗

Also known as: Dong Wha Pharmaceutical Co. Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 28, 2024

Timeline

1970s

Jun 1, 1973
DongWha Pharmaceutical Company— Founded

Drugs by trial phase (15 distinct, 18 trials)

Phase 4 (1 own, 0 via acquisition)

dapagliflozin

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

dw1029m

Phase 1 (11 own, 0 via acquisition)

Indications

Studied for

Recent trials (19)

NCT06875193Lead sponsorPhase 4May 28, 2024
NCT05823883Lead sponsorPhase 1Jun 30, 2023
NCT05823870Lead sponsorPhase 1Feb 24, 2023
NCT05874180Lead sponsorPhase 1Jan 9, 2023
NCT05874167Lead sponsorPhase 1Aug 8, 2022
NCT05403281Lead sponsorPhase 1Nov 5, 2021
NCT03127046Lead sponsorPhase 1Mar 31, 2017
NCT03282825Lead sponsorPhase 1Mar 28, 2017
NCT02212782Lead sponsorPhase 1Sep 1, 2014
NCT02212769Lead sponsorPhase 1Aug 1, 2014
NCT02212756Lead sponsorPhase 1Aug 1, 2014
NCT02212795Lead sponsorPhase 1May 1, 2014
NCT02004327Study directorPhase 1Dec 1, 2013
NCT02004327Lead sponsorPhase 1Dec 1, 2013
NCT01935167Lead sponsorPhase 2Oct 1, 2013

Details

Founded: Seoul, KR Jun 1, 1973
Last known activity: May 28, 2024